Skip to main content

Effects of (pre-)analytical variables on activated protein C resistance determined via a thrombin generation-based assay.

Curvers J, Christella M, Thomassen LG, de Ronde H, Bertina RM, Rosendaal FR, Tans G, Rosing J

Publication: Thromb Haemost (2002) • Vol 87 • Page 483-92PMID: 11924538View on PubMed

Purpose

The purpose of this paper was to determine the effects of patient genotype and condition, citrate concentration, delayed centrifugation, centrifugation protocol, frozen storage temperature, freeze-thaw cycling, and assay parameters on normalized activated protein C sensitivity ratio (nAPC-sr).

Conclusion

The highest nAPC-sr was observed in the woman who was heterozygous for factor V Leiden and also pregnant, but the other 2 individuals heterozygous for factor V Leiden had nAPC-sr levels that were comparable to those in the 5 healthy individuals not taking oral contraceptives and lower than those in the 3 wildtype individuals taking oral contraceptives. The largest factor affecting nAPC-sr was the citrate concentration followed by a 24 h delay in centrifugation. Only small effects were found after a 4 h delay in centrifugation, or between centrifugation protocols, frozen storage temperatures or 1 versus 2 freeze-thaw cycles. The nAPC-sr assay was also affected by APC, thrombin, calcium, and phospholipid concentrations.

Studies (1)

Purpose

The purpose of this study was to determine the effects of patient genotype and condition, trisodium citrate concentration, delayed centrifugation, centrifugation protocol, frozen storage temperature, freeze-thaw cycling, and assay parameters on nAPC-sr. Blood was obtained without pressure, and the first 2 mL were discarded. A single centrifugation at 2,000 x g for 15 min was compared to centrifugation at 3000 x g for 15 min followed by 20,000 x g for 30 min. All plasma was frozen at either -20 or -80 degrees C for 3 months before analysis.

Summary of Findings

The highest n-APC-sr was observed in the woman who was heterozygous for factor V Leiden and also pregnant, but the other 2 individuals heterozygous for factor V Leiden had nAPC-sr levels that were comparable to those in the 5 normal individuals not taking oral contraceptives and lower than those in the 3 normal individuals taking oral contraceptives. The largest factor affecting nAPC-sr was the citrate concentration with an average increase of 0.74 observed when the citrate concentration increased from 3.2 to 3.8%, and this increase was smaller in specimens with high nAPC-sr. An average increase in nAPC-sr levels of 0.149 was observed when centrifugation was delayed by 24 h compared to specimens that were centrifuged immediately. Only small effects were found after a 4 h delay in centrifugation (0.016), or between centrifugation protocols (0.089), frozen storage temperatures (0.023) or 1 versus 2 freeze-thaw cycles (0.035), but significance was not determined. The assay was also affected by APC, thrombin, calcium, and phospholipid concentrations.

  • Biospecimens

    FluidBlood
    FluidPlasma
  • Preservation Types

    Frozen
  • Diagnoses

    Normal
    Other diagnoses
    Pregnant
  • Platforms

    ProteinHematology/ auto analyzer
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Factor V Leiden heterozygous
    Normal
    Pregnant
    PreaquisitionOther drugs
    No oral contraceptives
    Oral contraceptives
    PreaquisitionPatient genotype
    Factor V Leiden heterozygous
    Normal
    Biospecimen AcquisitionAnticoagulant
    Multiple concentrations evaluated
    Sodium citrate
    Biospecimen Aliquots and ComponentsCentrifugation
    Centrifugation delays investigated
    Different number of centrifugation steps compared
    Multiple speeds compared
    StorageFreeze/thaw cycling
    1 cycle
    2 cycles
    StorageStorage temperature
    -20 degrees C
    -80 degrees C
    StorageTime at room temperature
    0 h
    24 h
    4 h
    Hematology/ auto analyzer SpecificReaction solution
    0-10 nM APC
    0-2.9 ng/mL Tissue factor
    0-32 mM CaCl2
    0-32 uM phospholipid